default author photo

Anna Di Lello

Università Vita-Salute San Raffaele - San Raffaele Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Impact of Platinum-Based Chemotherapy and CTLA-4 Inhibition on Acquired Resistance to First-Line Anti-PD-1/PD-L1 Agents in Non-Small Cell Lung Cancer: A Systematic Review and Reconstructed Individual Patient Data Analysis

Number of pages: 24 Posted: 26 Apr 2025
Università Vita-Salute San Raffaele - San Raffaele Hospital, University of Naples Federico II, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, University of Verona, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, University of Naples Federico II, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, University of Turin - Department of Oncology, Harvard University - Dana-Farber Cancer Institute, Imperial College London, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Laboratory of Methodology of Systematic Reviews and Guidelines Production, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology, AORN dei Colli - Monaldi Hospital and Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele
Downloads 97 (704,534)

Abstract:

Loading...

acquired resistance, platinum-based chemotherapy, CTLA-4 inhibitors, immunotherapy, non-small cell lung cancer